Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.
The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period – using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. “When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period,” he said. “This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment,” added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. “Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation,” said Melov. “We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention.”
“Little has been known about the functional ramifications of rapamycin in mammalian tissues,” said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. “These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life.” He added, “It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life.”
The Latest Bing News on:
Age-Related Heart Disease
- Heart Disease Newson May 1, 2024 at 5:00 pm
Unfavorable Social Factors May Raise Heart Disease Risk Factors in Asian American Adults Apr. 3, 2024 — Asian American adults with more unfavorable factors related to income level, education ...
- Coronary Heart Disease and Pregnancyon May 1, 2024 at 5:00 pm
Since women are delaying childbearing until older age, acute coronary syndrome ... the available information about pregnancy-related coronary heart disease. Yusuf Karamermer, Thorax Center ...
- Healthy vegetarian diets may boost longevity, slash heart disease death riskon May 1, 2024 at 9:30 am
A new study has found that people who adhere to a healthy pro-vegetarian diet have a lower risk of all-cause mortality and cardiovascular-related death.
- Anger could raise long-term risks for heart diseaseon May 1, 2024 at 7:37 am
Feeling angry constricts blood vessels in unhealthy ways and could raise a person's long-term odds for heart disease, new research warns.
- How getting angry may increase the risk of heart disease, strokeon April 30, 2024 at 5:00 pm
Using an established protocol, researchers assigned 280 young adults (average age 26) to one of four tasks designed ... Blood vessel dilation can lead to high blood pressure and related complications, ...
- Rare genetic condition may offer protection from heart diseaseon April 30, 2024 at 3:56 pm
A rare genetic condition, known as growth hormone receptor deficiency (GHRD) or Laron syndrome, may protect against cardiovascular disease.
- Heart Disease In Late 40s: Debunking Common Mythson April 29, 2024 at 10:53 am
Educating individuals about the actual risk factors, such as sedentary lifestyle, poor dietary habits, and stress, empowers them to take proactive measures to prevent heart diseases in late 40s.
- Rare Longevity Mutation Also Protects Against Heart Diseaseon April 29, 2024 at 1:10 am
A rare genetic mutation that has been linked to longevity also protects against heart disease and reduces the risk of some age-related diseases.
- Irregular bone marrow cells may increase heart disease riskon April 26, 2024 at 4:00 am
Over time, bone marrow stem cells develop key genetic errors and pass them on to immune cells. This may increase the risk of developing heart disease.
- Decline in heart failure deaths has been undone, led by people under 45on April 24, 2024 at 9:04 am
In heart failure, "the paradox is that at a time that we're seeing these increases in mortality, we also have access to better medications,” Mount Sinai Morningside's chief of cardiology said.
The Latest Google Headlines on:
Age-Related Heart Disease
[google_news title=”” keyword=”Age-Related Heart Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Rapamycin
- Rapamycin: Could a simple pill add years to your life?on May 2, 2024 at 7:00 pm
He has been taking Rapamycin for the past five years, a drug popular in the US for promoting longevity and anti-ageing. “I see Rapamycin as a second-level intervention,” says Samson, whose first ...
- Rapamycin shows promise in slowing Alzheimer's disease progression linked to seizureson May 2, 2024 at 11:37 am
The team found that an existing drug called rapamycin, initially developed as an immunosuppressant for organ transplant patients that suppresses signaling between neurons, was able to regulate the ...
- Could menopause be delayed? The answer could lead to longer lifespans for womenon May 2, 2024 at 8:23 am
Scientists are learning that ovaries aren't just important for making babies—they also keep the heart, brain, and bones healthy.
- Organ transplant drug may slow Alzheimer's disease progressionon May 1, 2024 at 11:29 am
Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer's disease (AD) who also experience seizures demonstrate more rapid cognitive decline than those who ...
- Biodexa shares rally 126% on rapamycin licensing dealon April 26, 2024 at 7:56 am
Biodexa licensed the rights from Rapamycin Holdings, which is doing business as Emtora Biosciences. The rights come with $17M in non-dilutive funding for a pivotal Phase 3 study of the drug in the ...
- Biodexa shares rally 126% on rapamycin licensing dealon April 26, 2024 at 6:56 am
Shares of Biodexa (NASDAQ:BDRX) soared 126% in early trading Friday after the company announced it had entered into an exclusive worldwide license to develop and commercialize eRapa, also known as ...
- Top 6 Best Rapamycin Supplements in 2024on April 25, 2024 at 5:00 pm
Rapamycin, a natural compound, has shown anti-aging and health benefits in various researches. Consequently, the popularity and demand for rapamycin supplements have surged significantly in the ...
- Could delaying menopause boost women's health? 1 woman shares her storyon April 25, 2024 at 4:56 am
(Double-blind means no one knows who receives the treatment and who receives the placebo.) Subjects are randomized to receive either rapamycin or a placebo. For three months, participants take a pill, ...
- Rapamycin: The Drug with a Potential to Extend Life and Combat Age-Related Diseaseson April 18, 2024 at 12:07 pm
Rapamycin, a drug traditionally used to prevent organ transplant rejection, has garnered attention for its potential as a longevity enhancer and a combatant against age-related diseases. The ...
- Social Media Claims This FDA-Approved Pill Can Slow Down Aging. Can It?on April 16, 2024 at 4:01 am
Age discrimination is rampant, and beauty standards favor youth. So it’s no wonder that people do anything they can to push back on aging, whether that’s using Botox for fewer wrinkles, hair dye to ...
The Latest Google Headlines on:
Rapamycin
[google_news title=”” keyword=”rapamycin ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]